Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-Corevalve bioprosthesis
Open Access
- 25 December 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 31 (7) , 857-864
Abstract
Prosthesis-patient mismatch (P-PM) is an important determinant of morbidity and mortality following open aortic valve replacement. The aims of this study were to report its incidence and determinants following transcatheter aortic valve implantation (TAVI) with the Corevalve bioprosthesis, which have—thus far—not been described. Patients with severe calcific aortic stenosis received TAVI with the Corevalve bioprosthesis via transfemoral route. Following TAVI, moderate P-PM was defined as indexed aortic valve effective orifice area (AVAi) ≤0.85 cm2/m2 and severe P-PM as AVAi ≤0.65 cm2/m2. Clinical, echocardiographic, and procedural factors relating to P-PM were studied. Optimal device position was defined on fluoroscopy as final position of the proximal aspect of the Corevalve stent frame 5–10 mm below the native aortic annulus. Between January 2007 and January 2009, 50 consecutive patients underwent TAVI in a single centre with the Corevalve bioprosthesis. Mean age was 82.8 years (SD 5.9; 70–93) and 48% were male. P-PM occurred in 16 of 50 cases (32%). Optimal position was achieved in 50% of cases. P-PM was unrelated to age, annulus size, LVOT size, Corevalve size, aortic angulation, ejection fraction, and sex. It was inversely correlated to optimal position (Spearman rho r = −0.34, P = 0.015). Those with optimal positioning had a 16% incidence of P-PM relative to 48% of those with suboptimal positioning (Pearson χ2P = 0.015). The incidence of P-PM following TAVI with the Corevalve bioprosthesis is compared favourably with that seen after AVR with conventional open stented bioprostheses and its occurrence is influenced by device positioning.Keywords
This publication has 36 references indexed in Scilit:
- The relevance of prosthesis–patient mismatch after aortic valve replacementNature Clinical Practice Cardiovascular Medicine, 2008
- Transapical minimally invasive aortic valve implantation; the initial 50 patients☆European Journal of Cardio-Thoracic Surgery, 2008
- Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic StenosisCirculation, 2007
- Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation Self-Expanding CoreValve ProsthesisJACC, 2007
- Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patientsEuropean Journal of Cardio-Thoracic Surgery, 2007
- Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve DiseaseCirculation, 2006
- Transapical Transcatheter Aortic Valve Implantation in HumansCirculation, 2006
- Treatment of Calcific Aortic Stenosis With the Percutaneous Heart ValveJACC, 2006
- Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosisJACC, 2004
- The problem of valve prosthesis-patient mismatch.Circulation, 1978